Mark Watkins-Fischl
Scientist of Purification Process Development at Medarex
Articles
Optimizing the Primary Recovery Step in Nonaffinity Purification Schemes for HuMAbs
Jue (Michelle) Wang, PhD;Deborah Perkins;Deena Aguiar;Mark Watkins-Fischl;Timothy Diehl;Alahari Arunakumari, PhD
March 2nd 2008An alternative approach to traditional Protein A schemes is comparable in overall efficiency, product recovery, and quality.
Latest Updated Articles
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: October 28th 2024 | Updated: November 21st 2024
Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development
Published: November 15th 2024 | Updated: November 21st 2024
Solving Challenges with AAV Aggregate Analysis Using a Novel Size Exclusion Particle to Determine CQAs
Published: October 28th 2024 | Updated: November 21st 2024
Cell-based phenotypic screening with Incucyte® Live-Cell Analysis Systems
Published: October 22nd 2024 | Updated: November 21st 2024
Optimizing cGMP Facility Design Space with a Hybrid Approach
